Administration, Sublingual
"Administration, Sublingual" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of a soluble dosage form by placement under the tongue.
| Descriptor ID |
D000286
|
| MeSH Number(s) |
E02.319.267.100.878
|
| Concept/Terms |
Administration, Sublingual- Administration, Sublingual
- Sublingual Drug Administration
- Sublingual Administration
- Administrations, Sublingual
- Sublingual Administrations
- Drug Administration, Sublingual
- Administration, Sublingual Drug
- Administrations, Sublingual Drug
- Drug Administrations, Sublingual
- Sublingual Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Sublingual".
Below are MeSH descriptors whose meaning is more specific than "Administration, Sublingual".
This graph shows the total number of publications written about "Administration, Sublingual" by people in this website by year, and whether "Administration, Sublingual" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Sublingual" by people in Profiles.
-
Grande LA, Hutch T, Jack K, Mironov W, Iwuoha J, Muy-Rivera M, Grillo J, Martin SA, Herring A. Ketamine-assisted buprenorphine initiation: a pilot case series. Addict Sci Clin Pract. 2024 Aug 29; 19(1):60.
-
Pbert L. Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support. Chest. 2006 Aug; 130(2):314-6.
-
Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Am J Addict. 2004; 13 Suppl 1:S42-66.
-
Zimrin D, Reichek N, Bogin KT, Aurigemma G, Douglas P, Berko B, Fung HL. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation. 1988 Jun; 77(6):1376-84.